Does a proton pump inhibitor cause hypokalemia?

Internal Medicine

Volumn 50, Issue 9, 2011, Pages 1045-1050

  Maeda, Yoshitaka ^a   Kojima, Naoki ^a   Araki, Yuya ^a   Uno, Tomomi ^a   Nishigaki, Keisuke ^a   Inaba, Naoto ^a  

^a Toride Kyodo General Hospital   (Japan)

Author keywords

H+,K+ ATPase; HK 1; HK 2; Hypomagnesaemia; Hypoparathyroidism; Omeprazole

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALFACALCIDOL; ASPARTATE POTASSIUM; BENIDIPINE; BETA 2 MICROGLOBULIN; BICARBONATE; C REACTIVE PROTEIN; CALCIUM; CREATININE; DRUG; EZETIMIBE; FAMOTIDINE; GLIMEPIRIDE; HEMOGLOBIN; ICOSAPENTAENOIC ACID; LAROXIFENE; MAGNESIUM; N ACETYL BETA GLUCOSAMINIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PARATHYROID HORMONE; POTASSIUM; POTASSIUM CHLORIDE; RALOXIFENE; TELMISARTAN; UNCLASSIFIED DRUG; UREA;

ACUTE KIDNEY FAILURE; AGED; ANEMIA; ANOREXIA; ARTICLE; CASE REPORT; CHRONIC GASTRITIS; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; EOSINOPHIL COUNT; FATIGUE; FEMALE; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; KIDNEY DISEASE; LABORATORY TEST; LEG EDEMA; LEUKOCYTE; MALAISE; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PROTEIN BLOOD LEVEL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINOPATHY; SIDE EFFECT; SUPPLEMENTATION; SYSTOLIC HEART MURMUR; TRANSTUBULAR POTASSIUM GRADIENT; UREA NITROGEN BLOOD LEVEL; UREMIA; URINALYSIS; URINARY EXCRETION; URINE PH; URINE SEDIMENT;

AGED; AGED, 80 AND OVER; FEMALE; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOKALEMIA; KIDNEY; OMEPRAZOLE; POTASSIUM; POTASSIUM, DIETARY; PROTON PUMP INHIBITORS; PROTON PUMPS;

EID: 79955625035     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4877     Document Type: Article

References (23)

1. + ATPases: physiology, regulation, and structure. Am J Physiol Renal Physiol 298: F12-F21, 2010.
2. Huber R, Kohl B, Sachs G, Senn-Bilfinger J, Simon A, Sturm E. Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole. Aliment Pharmacol Ther 9: 363-378, 1995.
3. Howden CW, Reid JL. Omeprazole, a gastric 'proton pump inhibitor': lack of effect on renal handling of electrolytes and urinary acidification. Eur J Cllin Pharmacol 26: 639-640, 1984.
4. Gau JT, Heh V, Acharya U, Yang YX, Kao TC. Uses of proton pump inhibitors and serum potassium levels. Pharmacoepidemiol Drug Saf 18: 865-871, 2009.
5. Geibel JP. Role of potassium in acid secretion. World J Gastroenterol 11: 5239-5265, 2005.
6. +-ATPase in renal intercalated cells. Toxicology 271: 45-50, 2010.
7. Kurtzman NA. Disorders of distal acidification. Kidney Int 38: 720-727, 1990.
8. Geevasinga N, Coleman PL, Webster AC, Roger SD. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol 4: 597-604, 2006.
9. Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: critical review. Clin Nephrol 68: 65-72, 2007.
10. Helander HF, Ramsay CH, Regardh CG. Localization of omeprazole and metabolites in the mouse. Scand L Gastroenterol Suppl 108: 95-104, 1985.
11. Dherbecourt O, Cheval L, Bloch-Faure M, Meneton P, Doucet A. Molecular identification of Sch28080-sensitive K-ATPase activities in the mouse kidney. Pflugers Arch 451: 769-775, 2006.
12. +-ATPase. Kidney Int 56: 2160-2167, 1999.
13. +-ATPases as therapeutic targets. Expert Opin Ther Targets 11: 881-890, 2007.
14. +-reabsorption in renal tubules. Clin Exp Nephrol 11: 1-6, 2007.
15. Patel AM, Goldfarb S. Got calcium? Welcome to the calciumalkali syndrome. J Am Soc Nephrol 21: 1440-1443, 2010.
16. Tal A, Powers K. Milk-alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism. J Natl Med Assoc 88: 313-314, 1996.
17. Kuipers MT, Thang HD, Arntzenius AB. Hypomagnasaemia due to use of proton pump inhibitors-a review. J Med 67: 169-172, 2009.
18. Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zieste R. A case series of proton pump-inhibitor-induced hypomagnesaemia. Am J Kidney Dis 56: 112-116, 2010.
19. Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol 69: 338-341, 2008.
20. Cundy T, Mackay J. Proton pump inhibitors and severe hypomagnesaemia. Curr Opin Gastroenterol 2010 [Epub ahead of print].
21. Huang C-L, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 18: 2649-2652, 2007.
22. Pham P-C T, Pham P-M T, Pham SV, Miller JM, Pham P-T T. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2: 366-373, 2007.
23. Ferrari P, Sansonnens A, Dick B, Frey FJ. In vivo 11β-HSD2, salt sensitivity, and effect of licorice. Hypertens 38: 1330-1336, 2001.